Home  >  Products  >  LPGAT1 (lysophosphatidylglycerol acyltransferase 1 ) Blocking Peptide (the C terminal of LPGAT1)(100ug)
LPGAT1 (lysophosphatidylglycerol acyltransferase 1 ) Blocking Peptide (the C terminal of LPGAT1)(100ug)

LPGAT1 (lysophosphatidylglycerol acyltransferase 1 ) Blocking Peptide (the C terminal of LPGAT1)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-LPGAT1 Antibody (ARP62465_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP62465
Size: 100ug
Weight: 41kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: Acyl-CoA:lysophosphatidylglycerol (LPG) acyltransferase catalyzes the reacylation of LPG to phosphatidylglycerol, a membrane phospholipid that is an important precursor for the synthesis of cardiolipin.
Alternative names: FAM34A; FAM34A1; NET8
See Full Product Listings >